These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5045595)

  • 41. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog.
    Kimura T; Uchida W; Satoh S
    J Pharmacol Exp Ther; 1985 Dec; 235(3):793-7. PubMed ID: 3001277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of tetrodotoxin on experimental arrhythmias.
    Huang TF
    Eur J Pharmacol; 1974 Apr; 26(1):77-81. PubMed ID: 4831986
    [No Abstract]   [Full Text] [Related]  

  • 43. Estimation of stroke volume in the dog by a pulse contour method.
    Kouchoukos NT; Sheppard LC; McDonald DA
    Circ Res; 1970 May; 26(5):611-23. PubMed ID: 4910134
    [No Abstract]   [Full Text] [Related]  

  • 44. Inability of potassium canrenoate to convert experimentally induced ouabain arrhythmias in the canine heart.
    Nielsen CJ; Lucchesi BR
    Circ Res; 1974 May; 34(5):635-40. PubMed ID: 4826935
    [No Abstract]   [Full Text] [Related]  

  • 45. Some aspects of the anti-arrhythmic activity of reserpine.
    Ciofalo F; Levitt B; Roberts J
    Br J Pharmacol Chemother; 1966 Oct; 28(1):44-50. PubMed ID: 5972620
    [No Abstract]   [Full Text] [Related]  

  • 46. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasma catecholamines following low and high doses of ouabain in anesthetized dogs with or without cervical vagotomy.
    Cousineau D; de Champlain J; Nadeau R; Péronnet F
    J Cardiovasc Pharmacol; 1980; 2(6):761-70. PubMed ID: 6160326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.
    Akera T; Larsen FS; Brody TM
    J Pharmacol Exp Ther; 1970 May; 173(1):145-51. PubMed ID: 4245610
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
    Singh J; Bala S; Kaur AH; Garg KN
    Indian J Physiol Pharmacol; 1980; 24(4):329-34. PubMed ID: 7216388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Some cardiovascular actions of sodium tauroglycocholate.
    Dave M; Prabhu S; Arora S; Sanyal RK
    Indian J Physiol Pharmacol; 1974; 18(2):93-6. PubMed ID: 4415816
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 53. Termination of ouabain-induced cardiac arrhythmias by anterior hypothalamic stimulation.
    Chinn C; Natelson BH
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):203-8. PubMed ID: 6200905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
    Yeh BK; Sung PK; Lazzara R
    Clin Pharmacol Ther; 1974 Dec; 16(6):1014-22. PubMed ID: 4433469
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
    Kaplan HR; Robson RD
    J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of CaC12 and BaC12 on the ventricular pacemaker of the rabbit].
    Usui A
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):73-82. PubMed ID: 5387679
    [No Abstract]   [Full Text] [Related]  

  • 58. Adrenoceptor mechanism involved in thiopental-epinephrine-induced arrhythmias in dogs.
    Hayashi Y; Kamibayashi T; Sumikawa K; Yamatodani A; Kuro M; Yoshiya I
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1380-5. PubMed ID: 7902006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The anti-arrhythmic activity of EDTA tetrabutylamide].
    Gendenshteĭn EI
    Biull Eksp Biol Med; 1966 Jul; 62(7):71-3. PubMed ID: 4988482
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanism of antiarrhythmic effect of dexmedetomidine on epinephrine-induced arrhythmias.
    Eisenach JC
    Anesthesiology; 1991 Dec; 75(6):1116-7. PubMed ID: 1683744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.